Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1β and nitric oxide in rat microglia

Archives of Pharmacal Research

Volumn 26, Issue 12, 2003, Pages 1067-1073

  Joo, Seong Soo ^a   Kang, Hee Chul ^a   Won, Tae Joon ^a   Lee, Do Ik ^a  

^a Chung Ang University   (South Korea)

Author keywords

Alzheimer s disease; IL 1 ; Microglia; Nitric oxide; Ursodeoxycholic acid (UDCA)

Indexed keywords

AUTACOID; INTERLEUKIN 1; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; URSODEOXYCHOLIC ACID;

ANIMAL; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MICROGLIA; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MICROGLIA; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; URSODEOXYCHOLIC ACID;

EID: 4143082506     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/BF02994760     Document Type: Article

References (29)

1. Banati, R. B., Gehrmann, J., Schubert, P., and Kreutzberg, G. W., Cytotoxicity of microglia.Glia, 7, 111–118 (1996). DOI: 10.1002/glia.440070117
2. Bayer, T. A., Wirths, O., Majtenyl, K., Hartmann, T., Multhaup, G., Beyreuther, K., and Czech, C., Key factors in Alzheimer’s disease: β-amyloid precursor protein processing, metabolism, and intraneuronal transport.Brain Pathology, 11, 1–11 (2001). DOI: 10.1111/j.1750-3639.2001.tb00376.x
3. Benveniste, E. N., Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action.Am. J. Physiol., 263, C1–16 (1992).
4. Beuers, U., Boyer, J. L., and Paumgartner, G., Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications.Hepatology, 28, 1449–1453 (1998). DOI: 10.1002/hep.510280601
5. Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. C., and Peterson, P. K., Activated microglia mediated neuronal cell injury via a nitric oxide mechanism.J. Immunol., 149, 2736–2741 (1992).
6. Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. H., and Brosnan, C., Microglia and cytokines in neurological disease, with special REFERENCe to AIDS and Alzheimer’s disease. [Review].Glia, 7, 75–83. (1993). DOI: 10.1002/glia.440070113
7. Forloni, G., Demichelli, F., Giorgi, S., Bendotti, C., and Angeretti, N., Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cell: modulation by interleukin-1.Brain. Res., 16, 128–134 (1992). DOI: 10.1016/0169-328X(92)90202-M
8. Giulian, D., Ameboid microglia as effectors of inflammation in the central nervous system.J. Neuroscience. Res., 18, 155–171 (1987). DOI: 10.1002/jnr.490180123
9. Giulian, D., Baker, T. J., Shih, L., and Lachman, L. B., Interleukin-1 of the central nervous system is produced by ameboid microglia.J. Exp. Med., 164, 594 (1986). DOI: 10.1084/jem.164.2.594
10. Hirano, F., Tanaka, H., Makino, Y., Okamoto, K., and Makino, I., Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression.J. Gastroenterol., 31 (1), 55–60 (1996). DOI: 10.1007/BF01211187
11. Invernizzi, P., Salzman, A. L., Szabo, C., Ueta, I., O’Connor, M., and Setchell, K. D., Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells an.in vivo.Am. J. Physiol., 273, G131–138 (1997).
12. Jaffrey, S. R. and Snyder, S. H., Nitric oxide: a neural messenger.Annu. Rev. Cell. Dev., 11, 417–440 (1995). DOI: 10.1146/annurev.cb.11.110195.002221
13. Joo, S. S., Chang, J. K., Park, J. H., Kang, H. C., and Lee, D. I., Immuno activation of lectin-conjugated praecoxin A on IL-6, IL-12 expression.Arch. Pharm. Res., 25, 954–963 (2002). DOI: 10.1007/BF02977019
14. Kim, S. H., Won, S. J., Sohn, S. H., Kwon, H. J., Lee, J. Y., Park, J. H., and Gwag, B. J., Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translocational activation of NADPH oxidase.J. Cell Biol., 159, 821–831 (2002). DOI: 10.1083/jcb.200112131
15. Kim, W. G., Mohney, R. P., Wilson, B., Heohn, G. H., Liu, B., and Hong, J. S., Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia.J. Neurosci., 20, 6309–6316 (2000).
16. Liu, L., Sakaguchi, T., Cui, X., Shirai, Y., Nishimaki, T., and Hatakeyama, K., Liver regeneration enhanced by orally administered ursodesoxycholic acid is mediated by immunosuppression in partially hepatectomized rats.Am. J. Chin. Med., 30 (1), 119–126 (2002). DOI: 10.1142/S0192415X02000132
17. Lue, L., Rydel, R., Brigham, E. F., Yang, L., Hampek, H., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., and Rogers, J., Inflammatory repertoire of Alzheimer’s disease and nondemented elderly microgli.in vitro.Glia, 35, 72–79 (2001). DOI: 10.1002/glia.1072
18. Lue, L. R and Walker, D. G., Modeling Alzheimer’s disease immune therapy mechanisms; interaction of human postmortem microglia with antibody- opsonized amyloid beta peptide.J. Neurosci. Res. 70 (4), 599–610 (2002). DOI: 10.1002/jnr.10422
19. Mrak, R. E., Sheng, J. G., and Griffin, W. S. T., Glial cytokines in Alzheimers disease: review and pathogenic implication.Hum. Pathol., 26, 816–823 (1995). DOI: 10.1016/0046-8177(95)90001-2
20. Paresce, D. M., Chung, H., and Maxfield, Slow degration of aggregates of the Alzheimers disease amyloid beta-protein by microglial cell.J. Biol. Chem., 272, 29390–29397 (1997). DOI: 10.1074/jbc.272.46.29390
21. Paumgartner, G. and Beuers, U., Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.Perspectives In Clinical Hepatology, 525–530 (2002).
22. Possel, H., Noack, H., Putzke, J., Wolf, G., and Sies, H., Selective upregulation of inducible Nitric Oxide Synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia.Glia, 32, 51–59 (2000). DOI: 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4
23. Rodrigues, C. M. P., Ma, X., Kren, B. T., and Streer, C. J., A novel role for ursodeoxycholic acid in inhibiting apotosis by modulating mitochondrial membrane perturbation.J. Clin. Invest., 101 (12), 2790–2799 (1998). DOI: 10.1172/JCI1325
24. Selkoe, D. J., The molecular pathology of Alzheimer’s disease. [Review.Neuron, 6, 487–498 (1991). DOI: 10.1016/0896-6273(91)90052-2
25. Shoda, M., Uber die Ursodeoxycholsaure aus Barengallen und ihre physiologische Wirkung.J. Biochem., 7, 505–517 (1927).
26. Strijbos, P. J. and Rothwell, N. J., Interleukin-1beta attenuates excitatory amino acid-induced neurodegenerstio.in vitro: involvement of nerve growth factor.J. Neurosci., 153, 3468–3474 (1995).
27. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D. A., Review: Alzheimers amyloid beta-peptide associated free radical oxidative stress and neurotoxicity.J. Structural Biol., 130, 184–208 (2000). DOI: 10.1006/jsbi.2000.4274
28. Webster, S. D., Park, M., Fonseca, M. I., and Tenner, A. J., Structural and functional evidence for microglial expression of C1qRP, the C1q receptor that enhances phagocytosis.J. Leukocyte Biology, 67, 109–116 (2000).
29. Yoshikawa, M., Tsujii, T., Matsumura, K., Yamao, J., Matsumura, Y., Kubo, R., Fukui, H., and Ishizaka, S., Immunomodulatory effects of ursodeoxycholic acid on immune responses.Hepatology, 16 (2), 358–364 (1992). DOI: 10.1002/hep.1840160213